🇪🇺 BNT162b6 Bivalent (Original/OMI BA.4/BA.5) in European Union

BNT162b6 Bivalent (Original/OMI BA.4/BA.5) (bnt162b6-bivalent-original-omi-ba-4-ba-5) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

BNT162b6 Bivalent (Original/OMI BA.4/BA.5) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is BNT162b6 Bivalent (Original/OMI BA.4/BA.5) approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for BNT162b6 Bivalent (Original/OMI BA.4/BA.5) in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.